1 Spier CM, "T-cell antigen-positive multiple myeloma" 3 : 302-307, 1990
2 Mishra P, "Plasmablastic transformation of plasma cell myeloma with heterotropic expression of CD3 and CD4: a case report" 72 : 250-253, 2017
3 Vega F, "Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles" 18 : 806-815, 2005
4 Taddesse-Heath L, "Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features" 23 : 991-999, 2010
5 Sun J, "Plasmablastic lymphoma involving the penis: a previously unreported location of a case with aberrant CD3 expression" 43 : 54-57, 2011
6 Yagci M, "Hepatic failure due to CD3+ plasma cell infiltration of the liver in multiple myeloma" 107 : 38-42, 2002
7 Luo X, "Dual CD3 and CD4 positive plasma cell neoplasm with indistinct morphology: a diagnostic pitfall" 48 : 378-380, 2016
8 Oliveira JL, "Clinicopathologic features of B-cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases" 36 : 1364-1370, 2012
9 Tang YL, "CD3 expression in plasma cell neoplasm (multiple myeloma): a diagnostic pitfall" 44 : 668-670, 2012
10 Gorczyca W, "Atlas of differential diagnosis in neoplastic hematopathology" CRC Press 359-381, 2014